Published in Health and Medicine Week, December 16th, 2002
Net loss for the quarter was $3,313,000 or $0.14 per diluted share as compared with net loss of $227,295,000 or $9.58 per diluted share for the first quarter of the previous fiscal year.
The prior year results reflect the adoption effective July 1, 2001 of Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets." Accordingly, during the first quarter of the previous fiscal year, NCS recorded a noncash charge of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.